Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
14.81 MXN
2.25 B MXN
4.25 B MXN
45.16 M
About Voyager Therapeutics, Inc.
Sector
Industry
CEO
Alfred W. Sandrock
Website
Headquarters
Lexington
Founded
2013
FIGI
BBG00PGH1JK4
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange VOYAGER THERAPEUTICS, INC stocks are traded under the ticker VYGR.
VYGR stock has risen by 6.72% compared to the previous week, the month change is a 6.72% rise, over the last year VOYAGER THERAPEUTICS, INC has showed a 6.72% increase.
We've gathered analysts' opinions on VOYAGER THERAPEUTICS, INC future price: according to them, VYGR price has a max estimate of 615.95 MXN and a min estimate of 143.72 MXN. Watch VYGR chart and read a more detailed VOYAGER THERAPEUTICS, INC stock forecast: see what analysts think of VOYAGER THERAPEUTICS, INC and suggest that you do with its stocks.
VYGR stock is 6.72% volatile and has beta coefficient of 1.27. Track VOYAGER THERAPEUTICS, INC stock price on the chart and check out the list of the most volatile stocks — is VOYAGER THERAPEUTICS, INC there?
Today VOYAGER THERAPEUTICS, INC has the market capitalization of 6.31 B, it has increased by 6.60% over the last week.
Yes, you can track VOYAGER THERAPEUTICS, INC financials in yearly and quarterly reports right on TradingView.
VOYAGER THERAPEUTICS, INC is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
VYGR earnings for the last quarter are −3.15 MXN per share, whereas the estimation was −8.76 MXN resulting in a 64.03% surprise. The estimated earnings for the next quarter are −8.44 MXN per share. See more details about VOYAGER THERAPEUTICS, INC earnings.
VOYAGER THERAPEUTICS, INC revenue for the last quarter amounts to 485.28 M MXN, despite the estimated figure of 230.58 M MXN. In the next quarter, revenue is expected to reach 292.43 M MXN.
VYGR net income for the last quarter is −178.20 M MXN, while the quarter before that showed −186.01 M MXN of net income which accounts for 4.20% change. Track more VOYAGER THERAPEUTICS, INC financial stats to get the full picture.
No, VYGR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 162.00 employees. See our rating of the largest employees — is VOYAGER THERAPEUTICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VOYAGER THERAPEUTICS, INC EBITDA is 278.41 M MXN, and current EBITDA margin is 50.58%. See more stats in VOYAGER THERAPEUTICS, INC financial statements.
Like other stocks, VYGR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VOYAGER THERAPEUTICS, INC stock right from TradingView charts — choose your broker and connect to your account.